Defense Tech Base Research workbooks

US 11987646 B2 / May 21, 2024

Immunomodulatory peptides

This disclosure provides peptides which can therefore be used for various therapeutic purposes, such as inhibiting the progression of a hyperproliferative disorder, including cancer; treating infectious diseases; enhancing a response to vaccination; treating sepsis; and promoting hair re-pigmentation or lightening of pigmented skin lesions.

Publication details

Recorded assignee
Leidos, Inc.
Publication number
US 11987646 B2
Publication type
Utility patent grant
Publication date
May 21, 2024
Filing date
Oct 8, 2021
CPC classes
A61P35/00, C07K7/08, A61K8/64, A61K35/17, A61K35/76, A61K38/10, A61K39/015, A61K39/39, A61K45/06, A61P31/00, A61Q7/00, C07K7/06, C07K14/7051, C07K14/70521, C07K16/2818, C12N15/86, A61K2300/00, A01K2227/105, A01K2267/0331, A61K2039/505, A61K2039/507, A61K2039/5256, A61K2039/55516, C07K2317/76, Y02A50/30
Inventors
Gutierrez; Gabriel M., Pannucci; James, Weil; Michael Ryan, Phares; Timothy W., Kotraiah; Vinayaka, Browne; Cecille D., Buontempo; Peter J.

Party names reflect the published document. Current ownership and legal status can change.

View patent publication →

Your defense tech briefing

Security verification will run before you submit.